Clinical Trial Update: Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Colistin versus Meropenem for ventilator-associated pneumonia caused by carbapenem-resistant Gram-negative bacteria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Colistin (colistin)
• Meropenem (Meropenem)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Ventilator-associated Bacterial Pneumonia | Phase 3 | Status: COMPLETED